Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,405,712
+$1,874,130 QoQ
Shares Held
17,508
+50.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#1,393
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $17,885,890 across 12 Drug Manufacturers - General names. ABBV ranks #1 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
17,508 | $4,405,712 | |
| 2 | JNJ |
Johnson & Johnson
|
12,574 | $3,193,418 | |
| 3 | LLY |
ELI LILLY & Co
|
2,498 | $2,996,175 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
17,214 | $2,174,816 | |
| 5 | AMGN |
Amgen Inc
|
5,256 | $1,903,301 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,663 | $1,627,195 | |
| 7 | PFE |
Pfizer Inc
|
51,109 | $1,230,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,625 | $208,872 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,405,712 | 17,508 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,531,582 | 11,640 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,719,715 | 11,903 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,525,385 | 6,588 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,138,156 | 11,519 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,087,028 | 9,961 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,996,814 | 11,237 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,223,822 | 11,261 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,899,584 | 11,075 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,167,354 | 11,902 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,597,585 | 10,309 | Shares | Sole | 2024-04-25 | |
| 2023-09-30 | $1,580,185 | 10,601 | Shares | Sole | 2024-04-25 | |
| 2023-06-30 | $1,519,754 | 11,280 | Shares | Sole | 2024-04-25 | |
| 2023-03-31 | $1,626,530 | 10,206 | Shares | Sole | 2024-04-25 | |
| 2022-12-31 | $1,782,881 | 11,032 | Shares | Sole | 2024-04-25 | |
| 2022-09-30 | $1,981,476 | 14,764 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,146,231 | 14,013 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $2,262,569 | 13,957 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $1,884,903 | 13,921 | Shares | Other | 2022-02-15 | |
| 2021-09-30 | $1,979,306 | 18,349 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,507,573 | 13,384 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $1,420,603 | 13,127 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $1,394,664 | 13,016 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $1,114,670 | 12,726 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $1,256,016 | 12,793 | Shares | Other | 2021-11-02 | |
| 2020-03-31 | $638,243 | 8,377 | Shares | Other | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||